We evaluated participants’ body weight, BMI, fasting blood glucose, fasting insulin, and HOMA-IR, as well as HbA1C in six studies that looked at the effects of FMT on weight and glycemic management in obesity and other metabolic disorders. The gene discussed is INS; the disease is obesity due to melanocortin 4 receptor deficiency.